MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
IMMP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immutep (IMMP) Ownership - Who owns Immutep?

Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
264 George Street
Phone
+61 283157003
Employees
44
Web
https://www.immutep.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
47.74M
P/E Ratio
N/A
Total Cash
159.26M
Projected Growth
N/A
Total Debt
1.68M
Revenue
N/A
Risk (Beta)
2.03
Dividend Yield
N/A
Total Cash/Share
1.08
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IMMP
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for IMMP
A.I. Advisor
published General Information

General Information

a developer of anti-cancer therapeutics

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
264 George Street
Phone
+61 283157003
Employees
44
Web
https://www.immutep.com